Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Severe Depression in Emergency Department Patients
NCT02106325Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Dec 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), sponsored by NYU Langone Health. Started Dec 2013; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02106325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106325.